JWBC
PFE icon

John W. Brooker & Co’s Pfizer PFE Stock Holding History

John W. Brooker & Co’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-70
Closed -$3K – 148
2022
Q3 		$3K Hold
70
– – ﹤0.01% 177
2022
Q2 		$4K Hold
70
– – ﹤0.01% 169
2022
Q1 		$4K Hold
70
– – ﹤0.01% 169
2021
Q4 		$4K Hold
70
– – ﹤0.01% 172
2021
Q3 		$3K Hold
70
– – ﹤0.01% 170
2021
Q2 		$3K Hold
70
– – ﹤0.01% 173
2021
Q1 		$3K Hold
70
– – ﹤0.01% 156
2020
Q4 		$3K Sell
70
-4
-5% -$147 ﹤0.01% 151
2020
Q3 		$3K Hold
74
– – ﹤0.01% 146
2020
Q2 		$2K Hold
74
– – ﹤0.01% 155
2020
Q1 		$2K Hold
74
– – ﹤0.01% 159
2019
Q4 		$3K Buy
+74
New +$2.64K ﹤0.01% 150

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

John W. Brooker & Co's PFE Position: Q4 2022 in Review

John W. Brooker & Co sold out of Pfizer (PFE) in Q4 2022, closing a stake of 70 shares — an estimated $3K sold.

John W. Brooker & Co first reported a position in PFE in Q4 2019 and held it in 12 quarters. The position peaked at $4K in Q2 2022. 3,265 funds tracked by Wall St. Rank hold PFE as of Q4 2022.

  • John W. Brooker & Co reported no remaining Pfizer position as of Q4 2022 after selling out during the quarter.
  • John W. Brooker & Co sold 70 Pfizer shares in Q4 2022, an estimated $3K.
  • John W. Brooker & Co first reported a position in Pfizer in Q4 2019 and held it in 12 quarters.
  • John W. Brooker & Co's Pfizer position peaked at $4K in Q2 2022.
  • 3,265 funds tracked by Wall St. Rank held Pfizer as of Q4 2022.

Based on John W. Brooker & Co's 13F filing for Q4 2022, filed 13 Jan 2023.